Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Prospects for the control of AIDS by immunizing seropositive individuals

Nature volume 327, pages 473–476 (1987)Cite this article

The long incubation period between infection and the development of clinical AIDS may be due to an immune response to the initial infection which persists with health and wanes with disease. If this response can be boosted, it may be possible to reduce the viral burden, prevent the development of disease and reduce contagiousness.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. 1. Gluckman J.C., Klatzmann D. & Montagnier L. A. Rev. Immun. 4,97–117(1986). 2. Fauci A.S. Proc. natn. Acad. Sci. U.S.A. 83, 9278–9283 (1986). 3. Barre–Sinoussi, F. etal. Science 220, 868–871 (1983). 4. Gallo, R.C. etal. Science224, 500–503 (1984). 5. Levy J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A. & Shimabukuro, J.M. Science 225, 840–842 (1984). 6. Bloom, B.R. & Rager–Zisma, B. in Viral Immunology and Immunopathology. (ed. Notkins A.L.) 113–136. (Academic, New York, 1975). 7. Pfizenmaier, K., Jung, H., Starsinski–Powitz, A., Rolling–hoff, M. & Wagner H. J. Immun. 119, 939–944 (1977). 8. Edgington, T.S. & Chisari, F.V. Am J Med Sci 270, 213–227(1975). 9. Peterson, J.M. Dienstag, J.L. & Purcell, R.H. in Viral Immunology and Immunopathology (ed. Notkins, A.L.) 213–235 (Academic, New York, 1975). 10. Adams, C.S., Crawford, T.B., Banks, K.L., McGuire, T.C. & Perryman, L.E. Infect Immun. 28 421–427 (1980). 11. McGuire, T.C. Concepts in Viral Pathogenesis. (eds. Notkins, A.L., Oldstone, M.B.A.) 225–230 (Springer, New York, 1984). 12. Klatzmann, D. & Gluckman, J.C. Immun. Today 7, 291–296(1986). 13. Wong–Staal, F. & Gallo, R.C. Nature 311, 395–403 (1985). 14. McDougal,J.S.era/. J Immun. 135,3151–3162(1985). 15. Folks, T. etal. J Immun. 136,4049–4053(1986). 16. Fauci, A.S. Proc Soc Acad Sci U.S.A. 83, 9278–9283 (1986). 17. Polk, B.F. etal. N. Engl. J. Med. 316, 61–66 (1987). 18. Weber, 3.N. et al Lancet 1,119–123(1987). 19. Steimer, K.S. etal. Virology 150, 283–290(1986). 20. Steimer, K.S. etal. Vaccines87(eds, Chanock, R., Brown, F., Levner, R. & Ginsberg, H.) (Cold Spring Harbor Laboratory, New York, in the press). 21. Laurence, J., Saunders, A. & Kulkosky, J. Science 235, 1501–1504(1987). 22. Klatzmann, D. et al. Science 225, 59–63 (1984). 23. Salk, }. et al.J Am med Assoc 515, 1169–1175(1953). 24. Meiklejohn, G. J Am medAssoc 179, 594–597 (1962). 25. Salk, J. & Salk, D. Science 195, 834–847 (1977). 26. Allison, A.C. & Byars, N.E. J Immun. Meth. 95, 157–168 (1986). 27. Hanson, C.V. Medical Virology 7/45–79 (eds. de la Maza, L.M., Peterson, E.M.) (Elsevier, New York 1983). 28. Salk. J. & Gori, J.B. Ann N.Y. Acad Sci 83, 609–637 (1960). 29. Salk, J.Ann N.Y. Acad Sci 61, 1023–1036(1955). 30. Salk, J. Lancet ii, 715–723 (1960). 31. Salk, D., van Wezel, A.L. & Salk, J. Lancet ii, 1317–1321 (1984). 32. Hadler, S.C. etal. New EnglJ. Med. 315, 209–214 (1986). 33. Francis, D.P. etal. Ann. intMed97, 362–366 (1982). 34. Szmuness, W. etal. New EnglJ Med 303, 833–841 (1980). 35. Salk, J., Romine, J.S., Westall, F.C. & Wiederholt, W.C. in The suppression of experimental allergic encephalo–myelitis and multiple sclerosis (eds. Davison, A.N. & Cuzner, M.L.) 141–156 (Academic, London, 1980). 36. Salk, J.Ann N.Y. Acad Sci 162, 365–380 (1969). 37. Letvin, N.L. etal. Science230, 71–73 (1985). 38. Koenig, S. etal. Science233, 1089–1093 (1986).

Download references

Author information

Authors and Affiliations

  1. Salk Institute for Biological Studies, PO Box 85800, San Diego, California, 92138-9216, USA

    Jonas Salk

Authors
  1. Jonas Salk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salk, J. Prospects for the control of AIDS by immunizing seropositive individuals. Nature 327, 473–476 (1987). https://doi.org/10.1038/327473a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/327473a0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing